DiamiR Biosciences Corp. (DIMR)
DiamiR Biosciences was planning to go public, but the IPO was withdrawn on Jul 14, 2025.
Stock Price: Pending
IPO price not available yet
DiamiR Biosciences Revenue
DiamiR Biosciences had revenue of $1.32M in the twelve months ending February 29, 2024. In the fiscal year ending May 31, 2023, DiamiR Biosciences had annual revenue of $1.13M, down -21.71%.
Revenue (ttm)
$1.32M
Revenue Growth
-21.71%
P/S Ratio
n/a
Revenue / Employee
$264,193
Employees
5
Market Cap
n/a
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2023 | 1.13M | -312.86K | -21.71% |
| May 31, 2022 | 1.44M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionDIMR News
- 1 year ago - Diagnostic test developer DiamiR Biosciences files for a $7 million IPO - Renaissance Capital
- 1 year ago - DiamiR Biosciences IPO Registration Document (S-1) - SEC